Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Report Date
Dr. Thomas J. Schall, PhDPresident and CEO2,148,6674.87%2015-03-30
Dr. Roger C. Lucas, PhDDirector67,0270.15%2015-05-21
Dr. Petrus (Pirow) Bekker, M.D.,PhDSVP of Medical & Clinical53,5940.12%2013-08-07
Dr. Joseph M. FeczkoDirector37,027less than 0.1%2015-05-21
Dr. Juan C. Jaen, PhDSVP, Drug Discovery & CSO30,000less than 0.1%2013-03-07
Mr. Thomas A. EdwardsN/A16,977less than 0.1%2015-07-28
Dr. Ira KleinDirector16,216less than 0.1%2015-05-21
James L. TyreeDirector14,324less than 0.1%2015-05-21
Mr. Geoffrey M. ParkerDirector13,514less than 0.1%2015-05-27
Dr. Markus J. Cappel, PhDChief Bus. Officer & Treasurer12,500less than 0.1%2015-03-05

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
BIOTECHNOLOGY VALUE FUND L P2015-11-04Sell360,0001,251,914$7252010
1,251,914 (See Explanation of Reponses)
BIOTECHNOLOGY VALUE FUND L P2015-11-02Sell50,0001,251,914$6.97348.510.47
1,251,914 (See Explanation of Reponses)
BVF PARTNERS L P/IL10% Owner2015-06-10Sell955,7001,251,914$98601.3-14.44
1,251,914 (See Explanation of Reponses)
Parker Geoffrey M.Director2015-05-27Sell13,51338,114$7.51101.52.5313,514 (Direct)
19,600 (By Geoffrey M Parker and Jill Gofen Parker Trustees of Geoffrey M Parker and Jill G Parker Revocable)
5,000 (By Delaware Charter Guarantee & Trust Company, Trustee FBO Mr. Geoffrey Monroe Parker IRA)
Tyree James LDirector2015-05-22Sell12,70314,324$7.4594.63.3614,324 (Direct)
KLEIN IRADirector2015-05-22Sell10,81116,216$7.4480.43.4916,216 (Direct)
Schall Thomas J.President and CEO
(Click for the stocks that their CEOs have bought)
2015-04-01Sell24,2672,148,667$7.51822.672,148,667 (Direct)
Schall Thomas J.President and CEO2015-03-25Sell9002,148,667$7.576.81.722,148,667 (Direct)
Schall Thomas J.President and CEO2015-03-24Sell50,3712,148,667$7.84394.9-1.792,148,667 (Direct)
Schall Thomas J.President and CEO2015-03-19Sell18,1462,148,667$8.34151.3-7.672,148,667 (Direct)
Schall Thomas J.President and CEO2015-03-17Sell31,3162,148,667$8.55267.8-9.942,148,667 (Direct)
Cappel Markus J.Chief Bus. Officer & Treasurer2015-03-09Sell34,12512,500$7.81266.5-1.4112,500 (Direct)
Cappel Markus J.Chief Bus. Officer & Treasurer2015-03-04Sell40,87512,500$7.98326.2-3.5112,500 (Direct)
Duliege Anne-MarieEVP, Chief of Strategic Dev.2014-11-18Sell4,9700$4.7123.463.48Link
Schall Thomas J.President and CEO2014-05-01Sell27,7262,148,667$5.5915537.752,148,667 (Direct)
Schall Thomas J.President and CEO2014-04-29Sell32,2742,148,667$5.38173.643.122,148,667 (Direct)
Cappel Markus J.Chief Bus. Officer & Treasurer2014-04-22Sell20,96212,500$8.17171.3-5.7512,500 (Direct)
Schall Thomas J.President and CEO2014-03-17Sell20,0002,148,707$7.251456.212,148,707 (Direct)
Schall Thomas J.President and CEO2014-02-18Sell20,0002,148,707$7.051419.222,148,707 (Direct)
Parker Geoffrey M.Director2013-12-06Buy20,00024,600$5.1510349.519,600 (Direct)
15,000 (By Geoffrey M Parker and Jill Gofen Parker Trustees of Geoffrey M Parker and Jill G Parker Revocable)

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column) and "Shares Owned Following This (Direct & Indirect)" transactions (sixth column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership